These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 4076839)

  • 1. Comparison of the antithrombotic and haemorrhagic effects of heparin and a new low molecular weight heparin in rats.
    Andriuoli G; Mastacchi R; Barbanti M; Sarret M
    Haemostasis; 1985; 15(5):324-30. PubMed ID: 4076839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombotic effect of OP/LMWH by subcutaneous route in rats.
    Fantuz M; Milani R; Andriuoli G; Mastacchi R; Barbanti M
    Arch Int Pharmacodyn Ther; 1986 Aug; 282(2):328-34. PubMed ID: 3767531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the antithrombotic and haemorrhagic effects of a low molecular weight heparin (LHN-1) and conventional heparin.
    Diness V; Nielsen JI; Pedersen PC; Wolffbrandt KH; Ostergaard PB
    Thromb Haemost; 1986 Jun; 55(3):410-4. PubMed ID: 3750271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic and bleeding effects of a low molecular weight heparin fraction.
    Pangrazzi J; Abbadini M; Zametta M; Naggi A; Torri G; Casu B; Donati MB
    Biochem Pharmacol; 1985 Sep; 34(18):3305-8. PubMed ID: 4038339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of antithrombotic and hemorrhagic effects of edoxaban, a novel factor Xa inhibitor, with unfractionated heparin, dalteparin, lepirudin and warfarin in rats.
    Morishima Y; Honda Y; Kamisato C; Shibano T
    Thromb Res; 2013 Aug; 132(2):234-9. PubMed ID: 23768448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental studies on the antithrombotic and haemorrhagic effects of heparin and a low molecular weight heparin derivative.
    Kaiser B; Hauptmann J; Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):119-25. PubMed ID: 2459005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralization of a low molecular weight heparin (LHN-1) and conventional heparin by protamine sulfate in rats.
    Diness V; Ostergaard PB
    Thromb Haemost; 1986 Dec; 56(3):318-22. PubMed ID: 3563964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo effects of low molecular weight heparins on experimental thrombosis and bleeding.
    Hirsh J
    Haemostasis; 1986; 16(2):82-6. PubMed ID: 3710297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic indications of low molecular weight heparins].
    Samama MM; Michaut-Paterno F
    Arch Mal Coeur Vaiss; 1991 Nov; 84(11 Suppl):1733-43. PubMed ID: 1662941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A low molecular weight heparin compared with unfractionated heparin.
    Thomas DP; Merton RE
    Thromb Res; 1982 Nov; 28(3):343-50. PubMed ID: 7179221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo neutralization of unfractionated heparin and low-molecular-weight heparin by a novel salicylamide derivative.
    Kuziej J; Litinas E; Hoppensteadt DA; Liu D; Walenga JM; Fareed J; Jeske W
    Clin Appl Thromb Hemost; 2010 Aug; 16(4):377-86. PubMed ID: 20460347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the antithrombotic and haemorrhagic effects of low molecular weight heparin fractions: the influence of the method of preparation.
    Cade JF; Buchanan MR; Boneu B; Ockelford P; Cater CJ; Cerskus AL; Hirsh J
    Thromb Res; 1984 Sep; 35(6):613-25. PubMed ID: 6506020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial reversal of low molecular weight heparin (PK 10169) anti-Xa activity by protamine sulfate: in vitro and in vivo study during cardiac surgery with extracorporeal circulation.
    Massonnet-Castel S; Pelissier E; Bara L; Terrier E; Abry B; Guibourt P; Swanson J; Jaulmes B; Carpentier A; Samama M
    Haemostasis; 1986; 16(2):139-46. PubMed ID: 3710291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study on the effects of a low molecular weight heparin (CY 216) and standard heparin in low dosage on experimental venous thrombosis.
    Doutremepuich C; Bousquet F; Gestreau GL; Toulemonde F; Bayrou B
    Haemostasis; 1987; 17(4):201-5. PubMed ID: 3623263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DHG, a new depolymerized holothurian glycosaminoglycan, exerts an antithrombotic effect with less bleeding than unfractionated or low molecular weight heparin, in rats.
    Kitazato K; Kitazato KT; Nagase H; Minamiguchi K
    Thromb Res; 1996 Oct; 84(2):111-20. PubMed ID: 8897700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic effects of YM-60828, a newly synthesized factor Xa inhibitor, in rat thrombosis models and its effects on bleeding time.
    Sato K; Kawasaki T; Hisamichi N; Taniuchi Y; Hirayama F; Koshio H; Matsumoto Y
    Br J Pharmacol; 1998 Jan; 123(1):92-6. PubMed ID: 9484858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated doses of oral and subcutaneous heparins have similar antithrombotic effects in a rat carotid arterial model of thrombosis.
    Hiebert LM; Ping T; Wice SM
    J Cardiovasc Pharmacol Ther; 2012 Mar; 17(1):110-6. PubMed ID: 21512111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low molecular weight heparin and haemodialysis: neutralization by protaminchloride.
    Andrassy K
    Blood Coagul Fibrinolysis; 1993 Dec; 4 Suppl 1():S39-43. PubMed ID: 8180328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Hirsh J; Raschke R
    Chest; 2004 Sep; 126(3 Suppl):188S-203S. PubMed ID: 15383472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulant and Antithrombotic Actions of AVE5026, an Enriched Anti-Xa Hemisynthetic Ultra-Low-Molecular-Weight Heparin.
    Hoppensteadt DA; Gray A; Jeske WP; Walenga JM; Fareed J
    Clin Appl Thromb Hemost; 2014 Sep; 20(6):621-8. PubMed ID: 23482722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.